These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10328600)

  • 41. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
    Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
    J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis and treatment of patients with testicular germ cell cancer.
    Hartmann JT; Kanz L; Bokemeyer C
    Drugs; 1999 Aug; 58(2):257-81. PubMed ID: 10473019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment outcome on 52 patients with 53 testicular germ cell tumors].
    Yokoyama M; Nemoto K; Kanemura M; Kitahara K; Oda H; Murata H; Matsunaga Y
    Hinyokika Kiyo; 1998 Nov; 44(11):789-94. PubMed ID: 9893223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
    Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
    J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
    Culine S; Théodore C; Bekradda M; Farhat F; Terrier-Lacombe MJ; Droz JP
    Am J Clin Oncol; 1997 Apr; 20(2):184-8. PubMed ID: 9124197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
    Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F
    Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of germ cell testicular cancer with pulmonary metastases.
    Schnorrer M; Ondrus D; Cársky S; Hornák M; Belan V; Kausitz J; Matośka J
    Neoplasma; 1996; 43(1):47-50. PubMed ID: 8843960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study.
    Nichols CR; Catalano PJ; Crawford ED; Vogelzang NJ; Einhorn LH; Loehrer PJ
    J Clin Oncol; 1998 Apr; 16(4):1287-93. PubMed ID: 9552027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
    Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
    Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
    Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
    Peckham MJ; Barrett A; Liew KH; Horwich A; Robinson B; Dobbs HJ; McElwain TJ; Hendry WF
    Br J Cancer; 1983 May; 47(5):613-9. PubMed ID: 6189504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Kawai T; Tanaka Y;
    Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
    Ikeda I; Shuin T; Yao M; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1993 Mar; 39(3):237-42. PubMed ID: 7685142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Kinetics of peripheral blood CD34-positive cells and the optimum timing for harvesting peripheral blood stem cells during BEP chemotherapy in patients with testicular germ cell tumor].
    Hioki T; Ogawa K; Yamada Y; Fumino M; Sugimura Y
    Nihon Hinyokika Gakkai Zasshi; 2000 Jan; 91(1):14-20. PubMed ID: 10689878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical study of testicular cancer].
    Tsumatani K; Ozono S; Momose H; Hirao Y; Okajima E; Kaneko Y; Watanabe S; Samma S; Yamada K
    Hinyokika Kiyo; 1996 Dec; 42(12):943-50. PubMed ID: 9013229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of germ cell tumors at the threshold of the third millennium].
    Géczi L; Biron P; Droz JP
    Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Testicular germ cell tumors: molecular understanding and clinical implications.
    Lutzker SG; Barnard NJ
    Mol Med Today; 1998 Sep; 4(9):404-11. PubMed ID: 9791864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors.
    Christian JA; Huddart RA; Norman A; Mason M; Fossa S; Aass N; Nicholl EJ; Dearnaley DP; Horwich A
    J Clin Oncol; 2003 Mar; 21(5):871-7. PubMed ID: 12610187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of advanced testicular cancer and toxicity of chemotherapy].
    Kawakita M; Matsuda T; Terachi T; Yoshida O
    Hinyokika Kiyo; 1999 Nov; 45(11):783-6. PubMed ID: 10637744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.